Filter
1256
Filtered Results: 1256
Text search:
U.S.
Food
and
Drug
Administration
Featured
Recommendations
119
New Publications
349
Language
Document type
No document type
737
Studies & Reports
191
Guidelines
186
Manuals
65
Strategic & Response Plan
37
Fact sheets
15
Training Material
12
Situation Updates
6
Brochures
2
Resource Platforms
2
Videos
2
Infographics
1
Countries / Regions
India
61
Global
42
Kenya
38
Ethiopia
36
Nigeria
32
Tanzania
29
South Africa
28
Uganda
27
Sierra Leone
24
Western and Central Europe
24
Liberia
24
Philippines
22
Myanmar / Burma
21
Rwanda
19
Zambia
18
Ghana
16
USA
12
Latin America and the Carribbean
12
Nepal
11
Cambodia
11
Bangladesh
11
Indonesia
11
Lesotho
9
Malawi
9
Eastern Europe
9
Russia
9
South Sudan
9
Africa
8
Congo, Democratic Republic of
8
Botswana
8
Colombia
7
Ukraine
7
Zimbabwe
7
Germany
7
West and Central Africa
7
Namibia
7
Middle East and North Africa
6
Syria
5
Mozambique
5
Haiti
5
Eastern Europe and Central Asia
5
Brazil
5
Thailand
4
Cameroon
4
Laos
4
South–East Asia Region
4
East and Southern Africa
4
Sudan
4
Eswatini/ Swaziland
4
Peru
3
Venezuela
3
Jordan
3
Paraguay
3
Argentina
3
Tajikistan
2
Senegal
2
Asia
2
Western Pacific Region
2
Vietnam
2
Sri Lanka
2
Central African Republic
2
Angola
2
Iraq
2
Somalia
2
Switzerland
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Iran
1
Singapore
1
Afghanistan
1
Qatar
1
Guinea
1
Guinea-Bissau
1
Lithuania
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Papua New Guinea
1
Yemen
1
Palestine
1
Mali
1
Libya
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
489
Clinical Guidelines
136
Public Health
59
Key Resources
40
Women & Child Health
38
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
Mental Health
107
TB
95
HIV
91
AMR
89
COVID-19
86
Pharmacy
60
NTDs
48
Rapid Response
34
Ebola & Marburg
33
Caregiver
29
NCDs
26
Planetary Health
23
Refugee
18
Specific Hazards
13
Conflict
13
Disability
11
Zika
8
Global Health Education
8
Cholera
7
Natural Hazards
6
Health Financing Toolbox
5
Social Ethics
4
Polio
4
An action research conducted in Bang Shau village Northern Shan State, Myanmar
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o...
Consultancy Report May 2022
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Training Manual
(You need free registration to download the book)
Disasters and public health emergencies can stress health care systems to the breaking point and disrupt delivery of vital medical services. During such crises, hospitals and long-term care facilities may be without power; trained staff, ambulances,...
The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to such unconventional attacks. The
possibility that...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
PLoS Med. 2009 Oct;6(10):e1000159. doi: 10.1371/journal.pmed.1000159. Epub 2009 Oct 6.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
